10 December 2025
10 December 2025
This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.
Later-stage financing deals for cell and gene therapy companies reflects a broader derisking trend in the pharma industry.
If passed into law, the BIOSECURE Act would have a major impact on US-China relationships in the pharma industry.
Golcadomide, a first-in-class oral CELMoD, has shown compelling activity as a monotherapy and with rituximab.
The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.
Zurzuvae was generally well-tolerated, with the most common side effects being sedation, somnolence and dizziness.
There are significant clinical unmet needs in the bipolar disorder treatment landscape.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
